Cheryl Reicin will co-present "Licensing Issues in the Life Sciences Industry." Topics include
- Research plan
- Due diligence
- Transitioning pharmaceutical products/programs
- Monetary considerations (e.g., royalties, product returns, etc.)
- IP rights considerations (e.g., ownership, licenses, retained rights, patent term extensions)
- Clinical stage vs. commercialized products
- Government rights and approvals (e.g., march-in rights, clinical trials, FDA approvals)
- Deal structures and governance
For more information, see the event website.